Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Primary Medical Care, Faculty of Medicine, University of Southampton, Southampton, UK.
Health Expect. 2019 Jun;22(3):373-384. doi: 10.1111/hex.12857. Epub 2019 Jan 10.
The Clinical Understanding and Research Excellence in ME/CFS group (CureME) at the London School of Hygiene & Tropical Medicine has supported and undertaken studies in immunology, genetics, virology, clinical medicine, epidemiology and disability. It established the UK ME/CFS Biobank (UKMEB), which stores data and samples from three groups: participants with ME/CFS, Multiple Sclerosis (MS) and healthy controls. Patient and public involvement have played a central role from its inception.
To explore the views of participants with ME/CFS and MS on CureME research findings, dissemination and future biomedical research priorities.
Five ME/CFS and MS focus groups were conducted at two UK sites. Discussions were transcribed and analysed thematically.
A total of 28 UKMEB participants took part: 16 with ME/CFS and 12 with MS. Five themes emerged: (a) Seeking coherence: participants' reactions to initial research findings; (b) Seeking acceptance: participants explore issues of stigma and validation; (c) Seeking a diagnosis: participants explore issues around diagnosis in their lives; (d) Seeking a better future: participants' ideas on future research; and (e) Seeking to share understanding: participants' views on dissemination. Focus groups perceived progress in ME/CFS and MS research in terms of "putting together a jigsaw" of evidence through perseverance and collaboration.
This study provides insight into the emotional, social and practical importance of research to people with MS and ME/CFS, suggesting a range of research topics for the future. Findings should inform biomedical research directions in ME/CFS and MS, adding patients' voices to a call for a more collaborative research culture.
伦敦卫生与热带医学院的 ME/CFS 临床理解与卓越研究小组(CureME)一直支持并开展免疫学、遗传学、病毒学、临床医学、流行病学和残疾方面的研究。它建立了英国 ME/CFS 生物银行(UKMEB),该银行存储了来自三组参与者的数据和样本:肌痛性脑脊髓炎(ME/CFS)、多发性硬化症(MS)和健康对照组。从一开始,患者和公众的参与就发挥了核心作用。
探讨 ME/CFS 和 MS 患者对 CureME 研究结果、传播和未来生物医学研究重点的看法。
在英国的两个地点进行了五次 ME/CFS 和 MS 焦点小组讨论。对讨论内容进行了转录和主题分析。
共有 28 名 UKMEB 参与者参加了研究:16 名 ME/CFS 和 12 名 MS。出现了五个主题:(a)寻求一致性:参与者对初始研究结果的反应;(b)寻求认可:参与者探讨了耻辱感和验证问题;(c)寻求诊断:参与者探讨了生活中的诊断问题;(d)寻求更好的未来:参与者对未来研究的想法;(e)寻求分享理解:参与者对传播的看法。焦点小组认为 ME/CFS 和 MS 研究取得了进展,通过坚持和合作,将证据“拼凑”在一起。
本研究深入了解了 MS 和 ME/CFS 患者对研究的情感、社会和实际重要性,为未来的研究提出了一系列研究课题。研究结果应能为 ME/CFS 和 MS 的生物医学研究方向提供信息,为更具协作性的研究文化增添患者的声音。